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LIST OF ABBREVIATIONS 
 
BCA, biliary cystadenoma 
BCC, biliary cystadenocarcinoma 
LT, liver transplantation 
CA 19-9, carbohydrate antigen 19-9 
α-FP, alpha-fetoprotein 
CEA, carcino-embryonic antigen 
POD, postoperative day 
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ABSTRACT 
Biliary cystadenoma is a rare benign cystic tumor of the liver. The mainstay of treatment 
is complete resection, either by enucleation or by formal hepatectomy, since incomplete 
removal entails not only constant recurrence but also the risk of malignant 
transformation to cystadenocarcinoma. A case of symptomatic centrohepatic biliary 
cystadenoma involving the main vasculo-biliary structures of the liver is reported. After 
an unsuccessful attempt at resection resulting in an intrahepatic biliary injury, relief of 
jaundice and radical excision were achieved by total hepatectomy and liver 
transplantation. The patient is now alive and well 4 years after transplant, disease-free, 
with normal liver and renal function while receiving everolimus monotherapy. This is the 
first report of liver transplantation performed for the treatment of this tumor. With the 
case on the background, diagnostic aspects and available therapeutic strategies for 
biliary cystadenoma are reviewed and discussed.     
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INTRODUCTION 
Biliary cystadenoma (BCA) is a rare benign tumor of the liver presenting usually as a 
large multiloculated cyst containing a variably coloured mucinous fluid. Histological 
examination reveals a limiting mucus-secreting cuboidal or columnar epithelium of 
biliary origin, frequently surrounded by a mesenchymal “ovarian-like” stroma [1,2]. When 
symptomatic, most frequent complaints include abdominal pain, mass effect, nausea 
and vomiting [3,4]. Occasionally BCAs can determine obstructive jaundice [5]. Owing to 
their origin and size, BCAs are frequently located close to the main hepatic vascular 
structures and can involve the bile ducts [1,5,6,7,8,9]. Curative treatment is based on 
complete excision, by either enucleation or formal hepatic resection, because 
incomplete removal implies constant recurrence and risk of malignant transformation to 
biliary cystadenocarcinoma (BCC) [4,6,10].  
In this paper, a case of BCA is illustrated in which relief of symptoms and complete 
excision could eventually be obtained in no other way than total hepatectomy and liver 
transplantation (LT). To our knowledge, this is the first report of LT performed for this 
indication. In the light of this case, diagnostic aspects and currently available therapeutic 
strategies for BCA are reviewed and discussed.     
 
CASE REPORT 
A 53-year-old woman was referred to our tertiary care center from a country hospital in 
October 2006 because of the discovery of a large lesion, 10 cm in diameter, centrally 
located in the liver across segments 4 and 8. She had a recent history of obstructive 
jaundice in the absence of abdominal symptoms. Magnetic resonance and computed 
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tomography imaging revealed a cystic mass with some septations in its caudal portion, 
lying on the Glissonian bifurcation and causing dislocation of the porta hepatis and 
compression of the main right and left hepatic ducts with peripheral bile duct dilatation 
(fig.1). On admission, total and conjugated bilirubin were 11.3 and 8.5 mg/dl, 
respectively, aspartate aminotransferase 77 U/L, alanine aminotransferase 137 U/L, 
gamma-glutamyltranspeptidase 107 U/L, alkaline phosphatase 357 U/L. Serum 
chemistries otherwise revealed normal liver function and normal carbohydrate antigen 
19-9 (CA 19-9), alpha-fetoprotein (α-FP) and carcino-embryonic antigen (CEA) levels. 
Serological testing for echinococcal disease was negative and she did not originate from 
an endemic area. Based on preoperative findings a clinical diagnosis of intrahepatic 
BCA was made and she was scheduled for open surgical exploration without delay. On 
operation, a centrohepatic round mass not abuting on the liver surface was observed. 
Cholecystectomy was performed and intraoperative cholangiography through the cystic 
duct stump confirmed external compression on both the right and left hepatic ducts 
(fig.2A). No communication between the cyst and the biliary tree was noted. The hepatic 
parenchyma covering the lesion was incised for a 2 cm depth on the anterior surface of 
the liver (segments 4-8) searching for a dissection plane along the cystic wall. The 
attempt at enucleation immediately failed due to the lack of an obvious anatomical plane 
between the cyst and the parenchyma, obliterated by the presence of dense fibrous 
tissue. The cyst was accidentally opened and unroofing of the lesion was carried out 
using a boundary of sponges to protect the abdomen from dissemination of cystic 
material. A large centrohepatic cavity eventually appeared with some internal septations 
arising from the floor, containing a mucinous, straw-coloured fluid. The main Glissonian 
pedicles imprinted the floor of the cavity, indicating strict anatomical relationship 
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between the cyst and the hilar plate. Results of frozen section examination of fragments 
of cystic wall were consistent with the preoperative diagnosis of BCA. After careful 
drainage and decompression, a second effort to perform enucleation of the lesion 
resulted in an injury to the right hepatic duct at the anterior/posterior bifurcation, as 
evidenced by repeated cholangiography. The irregular morphology of the entire 
intrahepatic biliary tree was patent at this time (fig.2B). A T-tube was inserted into the 
right hepatic duct through the injured wall. A further attempt to find a dissection plane 
between the cystic wall and the vasculo-biliary elements of the left hemi-liver failed, due 
to the ubiquitous presence of dense tissue around the cyst. At that time, continuation of 
surgery was deemed both useless and unsafe, because of the extensive and bilateral 
involvement of the main intrahepatic vasculo-biliary structures making radical excision of 
the BCA technically unfeasible by any type of liver resection (fig.3). The possibility of LT 
was immediately considered and more material from the cystic wall was obtained for 
histological examination in order to rule out malignancy. The T-tube was left in place for 
biliary drainage. Postoperative course was complicated by haemoperitoneum due to 
bleeding from the dissected intrahepatic areas, which required surgical revision and 
haemostasis with thrombin glue and filling of the open cavity with an omental flap on 
postoperative day (POD) 2. Final pathologic examination of the large biopsy samples 
confirmed the diagnosis of BCA; no areas of intestinal metaplasia or malignant 
degeneration were observed. Work-up for LT was rapidly completed. She was placed 
on the waiting list on POD 12, after signing a specific informative consent in which the 
risks of transplantation (morbidity/mortality of the procedure, need of long-term 
immunosuppression) were clearly explained in comparison with its expected benefits 
(complete and permanent relief of jaundice, radical excision of a lesion with a potential 
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for cancerous transformation). She was discharged home on POD 16, with the T-tube 
patent for drainage and a total bilirubin level of 2.8 mg/dl. A whole liver allograft from an 
AB0-compatible donor after brain death became available in November 2006, i.e. on 
POD 42 from the first surgery. Abdominal exploration at the time of LT evidenced no 
sign of extrahepatic dissemination of mucinous material. Omentectomy was performed 
en bloc with the native liver hepatectomy (fig.3). Transplant surgery was a routine using 
the piggy-back technique without veno-venous by-pass and the post-transplant course 
was uneventful with a discharge 7 days after LT. Explant pathology confirmed a cystic 
lesion lined by a single-layer columnar epithelium lying on a thick mesenchymal 
“ovarian-like” stroma (fig.4). No areas of malignant transformation were detected, 
confirming the pre-transplant diagnosis of BCA. She is now 4 years after LT, free from 
complications and disease recurrence, living a normal life in general good health. Since 
then, liver graft and renal functions have always remained normal, while 
immunosuppressive therapy was tapered from an initial scheme based on tacrolimus 
and mofetil mycophenolate to a current single-drug m-TOR inhibitor regimen (oral 
everolimus, Certican
®
, 2 mg bid to keep 5-6 ng/ml trough levels).  
 
DISCUSSION OF THE INDICATION  
First reported by Keen in 1892 [11], BCAs are usually large, multiseptated cysts limited 
by a cuboidal or columnar type epithelium. The presence of CA 19-9 in the epithelial 
layer evidenced by immunohistochemical analysis suggests their biliary origin [2]. The 
vast majority of BCAs are mucinous cystadenomas [2] and occur mostly in middle-aged 
females. About 85% of BCAs are surrounded by an “ovarian-like” stroma rich in spindle-
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shaped cells with prominent nucleoli; such stroma is observed only in females [12]. 
Reported incidence of BCAs is 5% of all hepatic cysts based on an autopsy series of 
1977 [13]. If for Regev [14] BCAs represent 11% of all large (≥ 4 cm) hepatic cysts 
referred for treatment, their finding remains definitely rare. Over the last 12 years, more 
than 1500 LTs and nearly 1000 liver resections were performed in our tertiary referral 
center in Northern Italy; yet, only 6 cases of BCA were encountered [personal 
unpublished data]. The presence of intestinal metaplasia of the epithelium constitutes 
the first sign of progression towards malignant BCC, which is finally characterized by the 
loss of epithelial architecture and nuclei stratification, cellular pleomorphism and 
infiltration of the underlying stroma [3]. Prevalence of BCC in the published series is 
highly variable ranging from 5 to 40 % of all BCAs [1,2,3,10].  
The most frequently referred symptom is abdominal pain, which is reported by 54–80% 
of patients [3,8,10,15,16]. Other symptoms include abdominal fullness or distension, 
anorexia, nausea and vomiting. Less frequently BCAs present with intracystic 
haemorrhage, intraperitoneal rupture or secondary infection. Inferior vena cava 
thrombosis due to mass effect has also been described [15]. Obstructive jaundice can 
result either from external compression or from polypoid protrusion of the lesion into the 
bile ducts [5,17]. Diagnosis is based mainly on radiological studies. BCAs appear 
typically as large multiloculated lesions with internal septations; sometimes a thickened 
wall presenting contrast-enhancement is observed [18,19,20]. Unfortunately, imaging is 
poorly specific in discriminating BCA from BCC, even if the finding of internal papillary 
vegetations may raise the concern for malignant degeneration. Serum α-FP and CEA 
levels are usually within normal values, while CA 19-9 levels can be elevated both in 
BCA and BCC [7]. Percutaneous aspiration and analysis of cyst fluid often reveals a 
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marked but variable elevation in CA 19-9 levels, consistent with the biliary origin of the 
cyst epithelium [21,22]. Cyst fluid CA 19-9 levels can help in differential diagnosis 
between BCA and hydatid or simple cysts, as they are usually normal or minimally 
elevated in the latter [21], but cannot help distinguish between BCA and BCC. If cyst 
fluid cytology can reveal the presence of atypical cells, false negative results are 
frequent since the technique often fails to retrieve malignant cells in case of BCC [7]. 
Therefore, cyst fluid analysis can be considered in the differential diagnosis with other 
cystic liver lesions, but has no role in discriminating BCA from BCC. Furthermore, it 
presents the theoretical risk of tumour seeding, with one well-documented case of 
pleural carcinomatosis following percutaneous aspiration of a BCC [7]. Finally, 
intraoperative examination of frozen sections was not completely reliable in some series 
[4,23,24,25], in which it resulted negative for a BCC that was discovered afterwards on 
the formalin-fixed specimen. This is why final pathology report is needed before making 
any further prognostic judgement and therapeutic decision.   
Appropriate surgical treatment of BCA, which is the „cholangiocellular‟ counterpart of the 
much more frequent „hepatocellular‟ adenoma, is based on the same principle of 
complete resection, either by enucleation or hepatectomy [26,27,28]. In fact, 
fenestration, marsupialization, aspiration, sclerosis, internal Roux-en-Y drainage and 
partial resection are followed by constant recurrence [4,6,28,29]. Complete resection is 
mandatory also because diagnosis of BCC can be an incidental one, i.e. made only on 
histological analysis of the surgical specimen [10]. In our experience all the six BCAs 
were excised completely, 5 by resectional surgery (4 partial hepatectomies, 1 
enucleation) and 1 by LT, with no recurrence at current follow-up [personal unpublished 
data]. Radical surgical excision of BCAs involving major bile ducts and determining 
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obstructive jaundice can be technically challenging, requiring a major hepatic resection 
sometimes associated with hepaticojejunostomy. Erdogan [5] described a series of 5 
patients (4 cystadenoma and 1 cystadenocarcinoma) presenting obstructive jaundice. 
Jaundice was intermittent in three patients and constant in two. In two patients 
obstruction was caused by a polypoid protrusion inside the bile ducts, in three by 
external compression. Communication between the cystic lesion and the biliary tree was 
noted in only one patient. All of them were successfully managed by complete resection 
of the lesion which required hepatectomy alone or associated with hepaticojejunostomy. 
In the series reported by Koffron [23] three of 34 patients had jaundice and were 
managed either by hepatic resection alone (2 patients) or by bisegmentectomy 
combined with hepaticojejunostomy. Successful management of large centrohepatic 
BCAs involving main vascular structures by enucleation of the lesion following the plane 
immediately close to its wall has been reported. A dissection plane can often be 
identified after drainage and decompression of the cyst [6,29]. In the absence of such 
plane (making for a BCA unresectable in totality), some Authors have recently published 
good results with partial or nearly-total resection associated with fulguration of the 
remnant inner epithelium with Argon beam coagulator [10,23]. However, outcomes of 
this procedure need further evaluation in the long run because partial resection entails 
not only the risk of recurrence, but also the possibility to leave in place pathologic tissue 
liable to undergo subsequent malignant transformation [4,30]. In this context, the 
existence of a cystadenoma-cystadenocarcinoma sequence can be postulated on the 
basis of the facts that approximately one third of BCCs present areas of benign 
epithelium and that BCC patients are on average 10-15 years older than the BCA ones 
[1,2,3].  
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In the present case, because of the clinical diagnosis of BCA and the peculiar location 
of the lesion, no attempt at preoperative biliary drainage was undertaken before the first 
laparotomy. Preoperative portal vein embolization (in view of the possibility of an 
extended liver resection) was not considered either, not only due to the cholestatic state 
with jaundice but also for the uncertainty of the type of resection potentially needed. 
Unfortunately, at surgical exploration, both enucleation and hepatectomy were not 
feasible. Thick and dense tissue had obliterated the space between the cystic 
epithelium and the main bilateral vasculo-biliary structures, making the efforts to find a 
dissection plane to enucleate BCA result in solely an intrahepatic biliary injury. In 
addition, a partial resection of the cyst with fulguration of the remnant inner epithelium, 
apart from its inherent risks (technical failure, recurrence and malignant transformation), 
would not have likely relieved the jaundice in this patient, in whom massive fibrous 
involvement of the biliary branches was present. These are the reasons why on the first 
operation LT was evoked as the best solution for the difficult situation. Indeed, LT has 
become an accepted therapy for end-stage liver disease with overall 1- and 5-year 
survival rates of 90% and 81%, respectively [31]. LT for benign hepatic lesions has been 
described in cases of adenoma and adenomatosis, focal nodular hyperplasia, 
haemangioma and haemangiomatosis, lymphangiomatosis, mesenchymal hamartoma, 
polycystic, Caroli‟s and hydatid diseases. Results in terms of 1- and 5-year survival are 
similar to those obtained for other indications [32,33].  
Regarding the final decision to proceed to LT, on the one hand, the risks associated 
with transplant surgery and long term immunosuppression were deemed largely 
“acceptable” for the patient in the lack of any other equally effective treatment. On the 
other hand, the concern about a potential post-LT recurrence in case of discovery of 
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areas of BCC in the explanted liver was counterbalanced by the presence of pre-LT 
arguments in favour of the benign nature of the lesion (i.e. presentation in a middle-
aged female with large and multiple formalin-fixed biopsy samples showing BCA with 
typical “ovarian-like” stroma, and no area of intestinal metaplasia). Therefore, the risk of 
recurrence of an hypothetical BCC after LT was considered “low” by the transplant 
team, i.e. comparable with that of recurrence of hepatocellular carcinoma after LT 
performed within Milan criteria [34]. Moreover, BCCs arising in association with a 
mesenchymal stroma usually have a less severe clinical course [2] and there are 
several reports of disease-free survival after complete resection [5,7,8,9].  
This report highlights once more the paramount importance of mastering the whole 
therapeutic armamentarium in liver surgery within the same institution. In fact, only in 
that setting a correct balance between perioperative risks and expected treatment 
outcomes can be made, and patients can be provided with the most appropriate 
surgical treatment. In other words, for subjects who do not present contraindications to 
LT, it is our conviction that today LT should be preferred to resectional surgery 
whenever the latter implies high risks with very little chance of success. 
In conclusion, the goal to be achieved when treating BCA remains complete excision. In 
the reported case, LT for symptomatic centrohepatic BCA allowed the removal of the 
tumor, relief of symptoms and 4-year disease-free survival. However, the benign nature 
of the lesion and the on-going shortage of organ donors limits the use of LT to the very 
selected cases of BCA not amenable to other forms of radical surgical therapy.  
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LEGENDS TO FIGURES 
 
Figure 1.       CT-scan pictures showing the mass effect exerted by the centrohepatic 
biliary cystadenoma. Note the dislocation of the left (A) and right (B) 
Glissonian pedicles and the close relationship with the hilar plate (B, 
C), determining diffuse biliary tree dilatation. Internal septations inside 
the cystic mass are visible (D).  
 
 
Figure 2. A. Intraoperative cholangiography obtained by injection of contrast 
material through the cystic duct after cholecystectomy: external 
compression of the primary biliary bifurcation and of the intrahepatic 
bile ducts is patent (arrows). 
B. Intraoperative cholangiography obtained by injection through the T-
tube inserted into the injured right bile duct after drainage and 
decompression of the cyst: extravasation of the contrast medium into 
the residual cavity and irregular morphology of the intrahepatic biliary 
tree are apparent. 
 
Figure 3.  Photograph of the explanted liver showing a hepatic vein (thin arrow) 
and internal septations (thick arrow) arising on the floor of the cyst. A 
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dissection plane between the cystadenoma and the hepatic bilio-
vascular structures does not appear identifiable (thick arrowhead).  
 
Figure 4.  Histological appearance of the lesion in the explant specimen (A, 
magnification 100 x; B, magnification 400 x). Note that a typical 
columnar epithelium, with several intracavitary papillary projections 
(arrows), is lying over a thick “ovarian-like” stroma rich in spindle cells 
(arrowhead). 
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